ArticleAnnals of internal medicine2020

In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.

Dominic L RacoPubMed ↗Publisher ↗

No numbers read from the abstract.